NCT06384456View on ClinicalTrials.gov

Topical TRanexamic Acid Vs. Placebo on Acute Postoperative Pain Following DRF Fixation

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Distal Radius Fractures
Interventions
DRUG

Topical TRanexamic Acid

10mL of 100mg/mL TXA will be administered into the surgical wound prior closure.

DRUG

Placebo

10mL of 100mg/mL normal saline will be administered into the surgical wound prior closure.

Trial Locations (1)

Unknown

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER